Opinion: My biggest GLP-1 ethical problem: patients who don’t want to stop
Stat News • 2/19/2026
Summary
Some GLP-1 patients are requesting to remain on the drugs for a longer period, creating an ethical dilemma for doctors. This situation raises concerns regarding the responsibilities and decisions faced by healthcare professionals in managing patient requests.
Advertisement
Lindy Score Breakdown (V4.2)
58d
Age
1
Sources
from cluster
1409
Hours Since Seen
Final Score0/100
CategoryAntiLindy
StatusArchived
Recency Multiplier0% (0.5^1409/48)
Hero EligibleNo
Score is 0 because recency decay (0.5^1409/48 = 0.000000) reduced it below 0.5
Score BreakdownRisk 50
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: 58 days - proven survivor
Stories gain Lindy status through source reputation, network consensus, and time survival.
Breaking Similar stories
Opinion: Don’t believe headlines saying that vaccine skepticism is widespread
Stat News • 1 day ago
STAT+: Researchers behind GLP-1 obesity drugs advance new approach: Drop GLP-1 as a target
Stat News • 2 days ago
STAT+: Cell therapy primed liver transplant patients to avoid organ rejection, small study shows
Stat News • 1 day ago
Opinion: Voice-first chatbots will exacerbate AI’s mental health threat
Stat News • 2 days ago
Opinion: The podcast bringing together MAHA and public health for hard conversations
Stat News • Today
Opinion: Health care is not ready for the new era of AI-enabled cyberattacks
Stat News • 1 day ago
Opinion: STAT+: The medical AI revolution requires rethinking health care’s architecture
Stat News • 2 days ago
A pancreatic cancer breakthrough, and new hope for an off-the-shelf CAR-T treatment
Stat News • 2 days ago
STAT+: Travere’s drug for a kidney disease doesn’t improve kidney function. The FDA approved it anyway
Stat News • 2 days ago
STAT+: HaloMD’s legal win highlights the difficulty of challenging arbitration decisions
Stat News • 2 days ago